Aptahem reports delay in delivery of its drug product
2019-02-08
Aptahem (publ) announced today that manufacture of its drug product has been delayed as a result of technical challenges. As a consequence, Aptahem anticipates that commencement of the planned clinical study for Apta-1 will be delayed. Aptahem reports that...
Read More